A Comparative Analysis of Immunorestoration and Recovery with Conventional and Immunotherapeutic Protocols in Canine Generalized Demodicosis: A Newer Insight of Immunotherapeutic Efficacy of T11TS

References

• Agarwala S. K., Chatterjee S., Mishra S. K. Immunpotentiation activity of a polyherbal formulation “Immuplus‐21” (research name). Phytomedica 2001; 2: 1–20
   Google Scholar
• Ardaur M. S.M., Newsholme F. A. Glucose and glutamine metabolism in lymphocytes of the rat. Biochem. J. 1983; 212: 835–842, [CSA]
   PubMedGoogle Scholar
• Barran M. M., Parker J. W. A simultaneous assay for T‐cells and B‐cells using immunobeads. Am. J. Clin. Pathol. 1985; 2: 182–189
   Google Scholar
• Basu S., Chaudhuri S., Roy B. Surface ultrastructural changes of Percoll separated splenic lymphocytes from syngenic and allogenic mice with transplantable ascites fibrosarcoma tumor. Indian J. Exp. Biol. 1982; 20: 227–281
   PubMedGoogle Scholar
• Bell G. M., Bolen J. B., Imboden J. B. Association of src‐like protein tyrosine kinases with the CD2 cell surface molecule in rat lymphocytes and natural killer cell. Mol. Cell. Biol. 1992; 12: 5548–5554, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Bierer B. E., Sleckman B. P., Ratnofsky S. E., Burakoff S. J. The biological role of CD2, CD4 and CD8 in T‐cell activation. Annu. Rev. Immunol. 1989; 7: 579–599, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Burkett G., Frank L. A., Bailey E. M., Schmeitzel L. P., Kania S. A. Immunology of dogs with juvenile onset generalized demodicosis as determined by lymphoblastogenesis and CD4:CD8 analysis. J. Vet. Allergy Clin. Immunol. 1996; 4(2)46–52, [CSA]
   Google Scholar
• Burrows A. K. Generalised demodicosis in the dog: the unresponsive or recurrent case. Aust. Vet. J. 2000; 78(4)244–246, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Chatterjee S. Effect of a herbal formulation (research name Immu‐21) on GM‐CSF. Macrophage maturation and splenic plaque forming cells in experimental animals. Indian J. Pharmacol. 2001; 33: 442–444
   Google Scholar
• Chatterjee S., Das S. N. Immupotentiation by Immu‐21in immunocompromised rats. Ancient Sci. Life 1997; 16: 200–205
   PubMedGoogle Scholar
• Chaudhuri S., Ganguly S., Ghosh S. N., Dutta S., Sarkar S., Bagum Z., Roy R. U., Bhattacharya M. K., Dutta S. K., Chaudhuri S. Immunological insurgence during intracranial tumor development: cellular immunity in astrocytoma patients. Indian J. Physiol. Appl. Sci. 2000; 54(3)118–129
   Google Scholar
• De‐Manualle T. C. Current treatment of canine demodicosis. 2003, Available at: http://www.small_animal_27htm (accessed Dec 2003)
   Google Scholar
• Demodicosis, Available at: http://www.upei.ca/∼cidd/Disease/dermatology/demodicosis.htm (accessed Jan 2004)
   Google Scholar
• Druckray H., Ivancovic S., Preussman R. Teratoginic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature 1966; 210: 1378–1379
   PubMedGoogle Scholar
• Dustin M. L., Selvarj P., Mattaliano R. J., Springer T. A. Purified lymphocyte function‐associated antigen3 binds to CD2 and mediates T lymphocyte adhesion. J. Exp. Med. 1987; 165: 677–687, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fox D. A., Hussey R. E., Fitzgerald K. A., Bensussan D., Daley J. F., Schlossman S. F., Reinherz E. L. Activation of human thymocytes via the 50 Kd T11 sheep erythrocytes binding protein induces the expression of interleukin 2 receptors on both T3 + and T3 − populations. J. Immunol. 1985; 134: 330–335, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Giegerich G. W., Hein W. R., Miyasaka M., Tifenthler G., Hunig T. Restricted expression of CD2 among subset of sheep thymocytes and T lymphocytes. Immunology 1989; 66: 354–361, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Gordon S. Alternative activation of macrophages. Nat. Rev. 2003; 3: 23–35, [CROSSREF]
   Google Scholar
• Hatikeyama M., Kono T., Kobayashi N., Kawahara A., Levin S. D., Perlmutter R. M. Interaction of the IL‐2 receptor with the src‐family kinase p56 lck: identification of novel intermolecular association. Science 1991; 252: 1523–1528
   PubMedGoogle Scholar
• Hudson L., Hay F. C. The lymphocytes: its role and function. Practical Immunology3rd ed. Blackwell Scientific Publications, Oxford 1989; 93–95
   Google Scholar
• Hunig T. The cell surface molecule recognized by the erythrocyte receptor of T‐lymphocytes. J. Exp. Med. 1985; 162: 890–901, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hunig T., Tifenthler G., Minacht R., Kohler C., Lottspeich F., Meuer S. The “erythrocyte receptor” of T‐lymphocytes and T11 target structure (T11TS): complementary cell interaction molecules involved in T‐cell activation. Behring Inst. Mitt. 1987; 81: 31–40, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Krensky A. M., Robbins E., Springer T. A., Burakoff S. J. LFA‐1, LFA‐2 and LFA‐3 antigens are involved in CTL‐target conjugation. J. Immunol. 1984; 132: 2180–2182, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kumar V., Nemmani S., Jena G. B., Dey C. S., Kaul C. L., Ramarao P. Cell proliferation and natural killer cell activity by polyherbal formulation, Immu‐21 in mice. Indian J. Exp. Biol. 2002; 40: 282–287, [CSA]
   PubMedGoogle Scholar
• Kumar P., Sharma S., Khanna M., Raj H. G. Effect of quercetin on lipid peroxidation and changes in experimental influenza virus infection. Int. J. Exp. Pathol. 2003; 84(3)127–133, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kwochka K. W. Demodicosis. Current Veterinary Dermatology: The Science and Art of Therapy, C. E. Griffin, K. W. Kwochka, J. M. Macdonald. Mosby Year Book, St. Louis 1993; 72–84
   Google Scholar
• Lantos P. L. Chemical Induction of tumors in nervous system. Neuro Oncology, G. T. Thomas. Churchill Livingstone, NewYork 1993; 85–107
   Google Scholar
• Law S., Maiti D., Palit A., Majumder D., Basu K., Chaudhuri S., Chaudhuri S. Facilitation of functional compartmentalization of bone marrow cells in leukemia mice by biological response modifiers: an immunotherapeutic approach. Immunol. Lett. 2001; 76: 145–152, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lemarie S. L., Horohv D. W. Evaluation of interleukin‐2 production and interleukin‐2 receptor expression in dogs with generalized demodicosis. Vet. Dermatol. 1996; 7: 3–10
   PubMedGoogle Scholar
• Meuer S. C., Hussey R. E., Fabbi M., Fox D., Acuto O., Fitzgerald K. A., Hodgdon J. C., Protentis J. P., Schlossman S. F., Reinherz E. L. An alternative pathway of T‐cell activation: a functional role for the 50 Kd T11 sheep erythrocyte receptor protein. Cell 1984; 36(4)897–906, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Mukherjee J., Dutta S., Sarkar S., Begum Z., Ghosh A., Chaudhuri S., Chaudhuri S. Preclinical changes in immunoreactivity and cellular architecture during the progressive development of the intracranial neoplasm and immunotherapeutic schedule with a novel biological response modifier. Asian Pacific J. Cancer Prev. 2002; 3: 325–337
   PubMedGoogle Scholar
• Mukherjee J., Sarkar S., Ghosh A., Duttagupta A. K., Chaudhuri S., Chaudhuri S. Immunotherapeutic effects of T11TS/S‐LFA‐3 against nitrosocompound mediated neural genotoxicity. Toxicol. Lett. 2004; 50(3)239–257, [CROSSREF]
   Google Scholar
• Parker J. W. Immunological basis for the redefinition of malignant lymphomas. Am. J. Clin. Pathol. 1976; 72: 670–686
   Google Scholar
• Plunkett M. L., Sanders M. E., Selvaraj P., Dustin M. L., Springer T. A. Rosetting of activated human T‐lymphocytes with autologus erythrocytes. Defination of the receptor and ligand molecules as CD2 and lymphocyte function associated antigen 3 (LFA‐3). J. Exp. Med. 1987; 165: 664–676, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Scott D. W., Miller W. H., Griffin C. E. Muller & Krik's Small Animal Dermatology6th ed. WB Saunders Co., Philadelphia 2001; 457–474
   Google Scholar
• Shaw S. E., Foster A. P. Treatment of canine adult‐onset demodicosis. Aust. Vet. J. 2000; 78(4)243–244, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Shipstone M. Generalised demodicosis in dogs, clinical perspective. Aust. Vet. J. 2000; 78(4)240–242, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Siliciano R. F., Prott J. C., Schmidt R. E. Activation of cytotoxic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature 1985; 317: 428–430, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Springer T. A., Dustin M. L., Kishimoto T. K., Marlin S. D. The lymphocyte function‐associated LFA‐1, CD2 and LFA‐3 molecules: cell adhesion receptors of the immune system. Annu. Rev. Immunol. 1987; 5: 223–252, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tani K., Morimoto M., Hayashi T., Inokuma H., Ohnishi T., Hayashiya S., Namura T., Une S., Nakaichi M., Taura Y. Evaluation of cytokine messenger RNA expression in peripheral blood mononuclear cells from dogs with canine demodicosis. J. Vet. Med. Sci. 2002; 64(6)513–518, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Taverne J., Bradley J. E. Immunity to protozoa and warms. Immunology5th ed., I. Roitt, J. Brostoff, D. Male. Mosby‐Year Book, Inc., USA 1998; 243–261
   Google Scholar
• van der Merwe P. A. A subtle role for CD2 in T cell antigen recognition. J. Exp. Med. 1999; 190(10)1371–1374, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Watanuki H., Gushiken Y., Takahashi A., Yasuda A., Sakai M. In vitro modulation of fish phagocytic cells by beta‐endorphin. Fish Shellfish Immunol. 2000; 10(2)203–212, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar